Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced dual-solvent recrystallization method achieving >97% purity. Ideal for reliable pharmaceutical intermediate suppliers seeking cost-effective purification.
Patent CN102746207B details a novel Oxiracetam synthesis using silyl protection, offering high purity and yield for reliable pharmaceutical intermediates supply chains.
Patent CN101925589B details a novel palladium-catalyzed process for 4-vinyl-23-dihydrobenzofuran ensuring high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN101130503B details a robust synthesis route for L-Serine-15N. Achieves high 15N abundance and purity for reliable supply chain integration.
Patent CN105272908B reveals a high-yield nitration process for Crizotinib intermediates offering substantial cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN109134402A reveals efficient one-step synthesis technology. Offers significant cost reduction and supply reliability for global pharmaceutical intermediate manufacturing partners.
Novel 3-step synthesis from 1-naphthol offers high purity (>99%) and cost efficiency. Reliable supply chain for API intermediates.
Patent CN103102357B details a low-toxicity synthesis route for Cefuroxime sodium offering improved yield and stability for pharmaceutical supply chains.
Patent CN1875018A reveals a safer, non-ether solvent reduction method for thiazolidinedione APIs, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel metal-free nitration method for 3-nitropyrrole using sodium nitrite. Offers high yield, safety, and cost reduction for pharmaceutical intermediates manufacturing.
Patent CN113804805A details a solvent-free method for synthesizing Pregabalin Impurity II. Achieve >99% purity for QC standards with reduced environmental impact.
Optimized synthesis of DOTA-EB-PSMA precursor reduces HPLC steps ensuring high purity and scalable supply for prostate cancer radioligand therapy manufacturing.
Patent CN108530398A reveals a one-step synthesis for high-purity epoxy-octanal. This method offers significant cost reduction and supply chain reliability for flavor manufacturers.
Patent CN116396275B reveals a one-pot cyanation strategy for Topiroxostat, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Discover a novel, non-Grignard synthesis for 1-cyclopropyl-2-(2-fluorophenyl) ethyl ketone. Enhanced safety, mild conditions, and scalable manufacturing for antithrombotic APIs.
Patent CN110256261B details a novel copper-coordinated chiral resolution method for high-purity L-2-amino-1-butanol, offering significant supply chain and cost advantages.
Patent CN103524308B reveals solid acid catalysis for high-purity halogenated phenol manufacturing with reduced waste and enhanced supply chain reliability.
Patent CN110656347B details a green electroreduction method for Olanzapine intermediates, eliminating toxic reagents and heavy metals for reliable pharmaceutical supply chains.
Patent CN108250236B reveals a novel ytterbium catalyst for efficient, solvent-free synthesis of alpha-hydroxy phosphates, offering significant cost and supply chain advantages.
Patent CN103351399B details a novel synthesis for trans hexa-atomic melon ring Q6*. This method offers significant supply chain and cost advantages for high-purity macrocyclic compounds.